Related Experiment Video
Updated: Apr 13, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Activated cdc42-associated kinase is up-regulated in non-small-cell lung cancer and necessary for FGFR-mediated AKT
Fengqing Hu1, Hongcheng Liu2, Xiao Xie1
1Department of Cardiothoracic Surgery, Xinhua Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
Abstract:
Activated cdc42-associated tyrosine kinase 1 (ACK1) has been reported to be implicated in non-small-cell lung cancer (NSCLC). However, the expression pattern and biological functions of ACK1 in the progression of NSCLC are not fully understood. In this study, it was found that the expression of ACK1 was significantly up-regulated in NSCLC samples compared to their adjacent normal tissues. Meanwhile, the expression of ACK1 was inversely correlated with the survival of NSCLC patients. Moreover, in the biological function studies, ACK1 was further validated to promote the growth, migration, and metastasis of NSCLC cells in vitro and in vivo. Mechanistically, ACK1 bind with FGFR1 and was essential for the phosphorylation of AKT induced by FGF. Our study demonstrated that ACK1 played an oncogenic role in the progression of NSCLC and ACK1 might be a promising target for the treatment of NSCLC.
Insights
Activated CDC42-associated tyrosine kinase 1 (ACK1) promotes non-small-cell lung cancer (NSCLC) growth, migration, and metastasis. Upregulated ACK1 expression correlates with poor survival, suggesting it as a potential therapeutic target for NSCLC.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Activated CDC42-associated tyrosine kinase 1 (ACK1) is implicated in non-small-cell lung cancer (NSCLC).
- The precise role and expression patterns of ACK1 in NSCLC progression remain incompletely elucidated.
- Understanding ACK1's function is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the expression profile of ACK1 in NSCLC tissues.
- To determine the biological functions of ACK1 in NSCLC cell growth, migration, and metastasis.
- To elucidate the molecular mechanism underlying ACK1's role in NSCLC progression.
Main Methods:
- Quantitative analysis of ACK1 expression in NSCLC and adjacent normal tissues.
- In vitro and in vivo assays to assess the impact of ACK1 on NSCLC cell behavior.
- Western blot analysis to examine protein interactions and phosphorylation states, specifically focusing on FGFR1, AKT, and FGF signaling pathways.
Main Results:
- ACK1 expression was significantly upregulated in NSCLC samples compared to normal tissues.
- ACK1 expression levels were inversely correlated with patient survival rates.
- ACK1 overexpression promoted NSCLC cell growth, migration, and metastasis in vitro and in vivo.
- ACK1 was found to bind with FGFR1 and mediate FGF-induced AKT phosphorylation.
Conclusions:
- ACK1 plays a significant oncogenic role in the progression of non-small-cell lung cancer.
- ACK1 promotes tumor growth, migration, and metastasis through interaction with FGFR1 and regulation of AKT signaling.
- ACK1 represents a promising therapeutic target for the treatment of NSCLC.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
Intracellular Signaling Affects Focal Adhesions
Some...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade

